| |
|
| |
 |
|
Peter M. Hecht, Ph.D.
Chief Executive Officer |
|
Brian M. Cali, Ph.D.
Vice President, Program Management |
|
Mark G. Currie, Ph.D.
Senior Vice President, R&D and Chief Scientific Officer |
| Mark Currie serves as Ironwood's senior vice president of research and development and chief scientific officer, and has led the Company's R&D efforts since joining Ironwood in 2002. Prior to joining Ironwood, he directed cardiovascular and central nervous system disease research as vice president of discovery research at Sepracor. Previously, Currie initiated, built, and led discovery pharmacology and also served as director of arthritis and inflammation at Monsanto/Searle. Currie earned a B.S. in biology from the University of South Alabama and holds a Ph.D. in cell biology from the Bowman-Gray School of Medicine of Wake Forest University. |
|
James M. DeTore
Vice President, Finance |
|
Halley Gilbert, Esq.
Vice President, Legal Affairs and General Counsel |
|
Michael J. Higgins
Chief Operating Officer and Chief Financial Officer |
|
Jeffrey M. Johnston, M.D., F.A.C.P.
Vice President, Clinical Development and Chief Medical Officer |
|
G. Todd Milne, Ph.D.
Vice President, Biology |
|
James J. O'Mara
Vice President, Business Development |
|
John J. Talley, Ph.D.
Senior Vice President, Drug Discovery |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
